$RLFTF
-
OTC News Robot wrote a new post, $RLFTF #OTCQB RELIEF THERAPEUTICS HLDG AG (RLFTF: OTCQB) | Relief Therapeutics Announces Promising Initial Stability Data on a New Formulation of RLF-100(R) (Aviptadil) 5 days, 16 hours ago -
OTC News Robot wrote a new post, $RLFTF #OTCQB RELIEF THERAPEUTICS HLDG AG (RLFTF: OTCQB) | Relief Therapeutics Announces Promising Initial Stability Data on a New Formulation of RLF-100(R) (Aviptadil) 5 days, 16 hours ago
-
OTC News Robot wrote a new post, $RLFTF #OTCQB RELIEF THERAPEUTICS HLDG AG (RLFTF: OTCQB) | Acer Therapeutics and Relief Therapeutics Announce ACER-001 IND Submission for the Treatment of Maple Syrup Urine Disease 1 week, 4 days ago
-
OTC News Robot wrote a new post, $RLFTF #OTCQB RELIEF THERAPEUTICS HLDG AG (RLFTF: OTCQB) | Acer Therapeutics and Relief Therapeutics Announce ACER-001 IND Submission for the Treatment of Maple Syrup Urine Disease 1 week, 4 days ago
-
OTC News Robot wrote a new post, $RLFTF #OTCQB RELIEF THERAPEUTICS HLDG AG (RLFTF: OTCQB) | Relief Therapeutics Announces Effectiveness of Registration Statement on Form 20-F 2 weeks, 4 days ago
-
OTC News Robot wrote a new post, $RLFTF #OTCQB RELIEF THERAPEUTICS HLDG AG (RLFTF: OTCQB) | Relief Therapeutics Announces Effectiveness of Registration Statement on Form 20-F 2 weeks, 4 days ago
-
OTC News Robot wrote a new post, $RLFTF #OTCQB RELIEF THERAPEUTICS HLDG AG (RLFTF: OTCQB) | Relief Therapeutics Announces that its Collaboration Partner has Resubmitted the ACER-001 (Sodium Phenylbutyrate) New Drug Application (NDA) to the FDA for the Treatment of Urea Cycle Disorders (UCDs) 3 weeks ago
-
OTC News Robot wrote a new post, $RLFTF #OTCQB RELIEF THERAPEUTICS HLDG AG (RLFTF: OTCQB) | Relief Therapeutics Announces that its Collaboration Partner has Resubmitted the ACER-001 (Sodium Phenylbutyrate) New Drug Application (NDA) to the FDA for the Treatment of Urea Cycle Disorders (UCDs) 3 weeks ago
- Load More